Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yifang Li

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Journal of Inflammation Research|August 15, 2022
From Suspicion to Diagnosis: Analysis on the Clinical Characteristics of 37 Cases of IgG4-Related Disease (IgG4-RD) in Northeast ChinaShanshan Zhang, Jun Zhang, Yifang Li, et al.
Frontiers in Medicine|August 13, 2025
Independent role of two novel abdominal fat indicators in chronic diarrhoeaShiming Chen, Jingxia Zhang, Yingxue Niu, et al.
International Journal of Molecular Sciences|June 10, 2022
Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney DiseaseYifang Li, Sharon D Ricardo, Chrishan S Samuel
Translational Vision Science & Technology|November 17, 2022
Topical Ocular TRPV1 Antagonist SAF312 (Libvatrep) Demonstrates Safety, Low Systemic Exposure, and No Anesthetic Effect in Healthy ParticipantsKalliopi Stasi, Qusai Alshare, Monish Jain, et al.
British Journal of Pharmacology|December 23, 2022
Functional crosstalk between angiotensin receptors (types 1 and 2) and relaxin family peptide receptor 1 (RXFP1): Implications for the therapeutic targeting of fibrosisChrishan S Samuel, Yifang Li, Yan Wang, et al.
Pharmacological Research|April 13, 2026
Roles of Peroxisome Proliferator-Activated Receptors (PPARs) in Pancreatic Metabolic DiseasesXiaoping Han, Ying Geng, Yifang Li, et al.
Frontiers in Digital Health|June 19, 2026
Construction and prototype effect evaluation of a multi-agent collaborative system for operating room nursingYifang Li, Jingfei Zou, Ling Wang, et al.
Reviews in Endocrine & Metabolic Disorders|August 16, 2021
Applications of artificial intelligence (AI) in researches on non-alcoholic fatty liver disease(NAFLD) : A systematic reviewYifang Li, Xuetao Wang, Jun Zhang, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 14, 2021
Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD)Yifang Li, Yanzhen Chen, Xing Tian, et al.
Experimental and Therapeutic Medicine|August 4, 2020
Radiographic study of Sever's diseaseYan Gao, Jia Liu, Yifang Li, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Journal of Inflammation Research|August 15, 2022
From Suspicion to Diagnosis: Analysis on the Clinical Characteristics of 37 Cases of IgG4-Related Disease (IgG4-RD) in Northeast ChinaShanshan Zhang, Jun Zhang, Yifang Li, et al.
Frontiers in Medicine|August 13, 2025
Independent role of two novel abdominal fat indicators in chronic diarrhoeaShiming Chen, Jingxia Zhang, Yingxue Niu, et al.
International Journal of Molecular Sciences|June 10, 2022
Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney DiseaseYifang Li, Sharon D Ricardo, Chrishan S Samuel
Translational Vision Science & Technology|November 17, 2022
Topical Ocular TRPV1 Antagonist SAF312 (Libvatrep) Demonstrates Safety, Low Systemic Exposure, and No Anesthetic Effect in Healthy ParticipantsKalliopi Stasi, Qusai Alshare, Monish Jain, et al.
British Journal of Pharmacology|December 23, 2022
Functional crosstalk between angiotensin receptors (types 1 and 2) and relaxin family peptide receptor 1 (RXFP1): Implications for the therapeutic targeting of fibrosisChrishan S Samuel, Yifang Li, Yan Wang, et al.
Pharmacological Research|April 13, 2026
Roles of Peroxisome Proliferator-Activated Receptors (PPARs) in Pancreatic Metabolic DiseasesXiaoping Han, Ying Geng, Yifang Li, et al.
Frontiers in Digital Health|June 19, 2026
Construction and prototype effect evaluation of a multi-agent collaborative system for operating room nursingYifang Li, Jingfei Zou, Ling Wang, et al.
Reviews in Endocrine & Metabolic Disorders|August 16, 2021
Applications of artificial intelligence (AI) in researches on non-alcoholic fatty liver disease(NAFLD) : A systematic reviewYifang Li, Xuetao Wang, Jun Zhang, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 14, 2021
Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD)Yifang Li, Yanzhen Chen, Xing Tian, et al.
Experimental and Therapeutic Medicine|August 4, 2020
Radiographic study of Sever's diseaseYan Gao, Jia Liu, Yifang Li, et al.
Pageof 10